Vir Biotechnology, Inc.
VIR· Nasdaq
Released Nov 2, 2023, after the close
10-Q filed Nov 3, 2023, 34 days after period end · 0001628280-23-036702
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $2.64M | $374.56M | $103.62M | $1.93M |
| Net Income | -$163.41M | $175.31M | $110.43M | -$84.61M |
| EPS Diluted |
Vir Biotechnology, Inc. · CIK 1706431 · Engraved from SEC EDGAR
| -$1.22 |
| $1.30 |
| $0.82 |
| -$0.67 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.